SABSW supply chain intelligence for SAB Biotherapeutics, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
SAB Biotherapeutics, Inc. (SABSW) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| BDRX | Biodexa Pharmaceuticals Plc | 72% | Reciprocal relationship from BDRX graph: ll therapies by Vertex Pharmaceuticals, Inc. and CRISPR Therapeutics AG and SAB Biotherapeutics, Inc. is developing an immunotherapeutic. The JDRF T1D Fund ha… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| SABSW-DEBT-12350 | Warrants outstanding: 0.01 | 90% | xbrl warrant detail from xbrl 2024-12-31. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| BDRX | Biodexa Pharmaceuticals Plc | 100.00 | 1 | ['customer'] |
| RXRX | Recursion Pharmaceuticals, Inc. | 50.00 | 2 | |
| CNSP | CNS Pharmaceuticals, Inc. | 50.00 | 2 | |
| CGON | CG Oncology, Inc. | 50.00 | 2 | |
| CRSP | CRISPR Therapeutics AG | 50.00 | 2 | |
| TARA | Protara Therapeutics, Inc. | 50.00 | 2 | |
| COGT | Cogent Biosciences, Inc. | 50.00 | 2 | |
| GSK | GSK plc | 50.00 | 2 | |
| TPST | Tempest Therapeutics, Inc. | 50.00 | 2 | |
| MANU | Manchester | 50.00 | 2 | |
| SLN | Silence Therapeutics plc | 50.00 | 2 | |
| PSTV | Plus Therapeutics, Inc. | 50.00 | 2 | |
| SABS | SAB Biotherapeutics, Inc. | 50.00 | 2 |